Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pfizer’s Champix Approved In Japan

This article was originally published in PharmAsia News

Executive Summary

TOKYO - Pfizer is hoping to launch its smoking cessation aid Champix (varenicline) in Japan in April after receiving manufacturing and marketing approval from the Ministry of Health Labor and Welfare Jan. 25, Pfizer Japan told PharmAsia News

You may also be interested in...

Pfizer's Sutent Approved In Japan

Pfizer's Sutent Approved In Japan

Pfizer Plans to Launch Anti-Smoking Chantix in India by End of February

NEW DELHI - On the heels of a study showing one million people die yearly in India from smoking-related illness, Pfizer plans to launch its anti-smoking tablet Chantix (varenicline) by the end of the month, Pfizer India told PharmAsia News




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts